DENTSPLY SIRONA
Market Cap
US$12.8b
Last Updated
2020/02/22 00:33 UTC
Data Sources
Company Financials +
Executive Summary
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide.
Rewards
Risk Analysis
Snowflake Analysis
Excellent balance sheet with moderate growth potential.
Similar Companies
Share Price & News
How has DENTSPLY SIRONA's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: XRAY has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-1.7%
XRAY
-1.3%
US Medical Equipment
-1.0%
US Market
1 Year Return
36.6%
XRAY
19.7%
US Medical Equipment
18.0%
US Market
Return vs Industry: XRAY exceeded the US Medical Equipment industry which returned 19.7% over the past year.
Return vs Market: XRAY exceeded the US Market which returned 18% over the past year.
Shareholder returns
| XRAY | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.7% | -1.3% | -1.0% |
| 30 Day | -4.7% | -0.9% | 0.6% |
| 90 Day | -0.7% | 7.0% | 7.9% |
| 1 Year | 37.5%36.6% | 20.6%19.7% | 20.4%18.0% |
| 3 Year | -7.6%-9.5% | 79.4%74.4% | 48.0%38.5% |
| 5 Year | 10.7%7.2% | 115.3%92.8% | 72.2%53.3% |
Price Volatility Vs. Market
How volatile is DENTSPLY SIRONA's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall St
What Is DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Share Price Doing?3 weeks ago | Simply Wall St
Why We’re Not Keen On DENTSPLY SIRONA Inc.’s (NASDAQ:XRAY) 5.1% Return On Capital1 month ago | Simply Wall St
Should You Use DENTSPLY SIRONA's (NASDAQ:XRAY) Statutory Earnings To Analyse It?Valuation
Is DENTSPLY SIRONA undervalued compared to its fair value and its price relative to the market?
12.2%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: XRAY ($56.85) is trading below our estimate of fair value ($64.78)
Significantly Below Fair Value: XRAY is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: XRAY is poor value based on its PE Ratio (78.2x) compared to the Medical Equipment industry average (46.6x).
PE vs Market: XRAY is poor value based on its PE Ratio (78.2x) compared to the US market (18.2x).
Price to Earnings Growth Ratio
PEG Ratio: XRAY is poor value based on its PEG Ratio (2.7x)
Price to Book Ratio
PB vs Industry: XRAY is good value based on its PB Ratio (2.5x) compared to the US Medical Equipment industry average (4.1x).
Next Steps
Future Growth
How is DENTSPLY SIRONA forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?
29.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: XRAY's forecast earnings growth (29.5% per year) is above the savings rate (1.7%).
Earnings vs Market: XRAY's earnings (29.5% per year) are forecast to grow faster than the US market (14.2% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: XRAY's revenue (3.5% per year) is forecast to grow slower than the US market (7.6% per year).
High Growth Revenue: XRAY's revenue (3.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: XRAY's Return on Equity is forecast to be low in 3 years time (11.5%).
Next Steps
Past Performance
How has DENTSPLY SIRONA performed over the past 5 years?
-48.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: XRAY has a large one-off loss of $100.5M impacting its September 30 2019 financial results.
Growing Profit Margin: XRAY became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: XRAY has become profitable over the past 5 years, growing earnings by -48% per year.
Accelerating Growth: XRAY has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: XRAY has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).
Return on Equity
High ROE: XRAY's Return on Equity (3.2%) is considered low.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is DENTSPLY SIRONA's financial position?
Financial Position Analysis
Short Term Liabilities: XRAY's short term assets ($1.8B) exceed its short term liabilities ($868.9M).
Long Term Liabilities: XRAY's short term assets ($1.8B) do not cover its long term liabilities ($2.4B).
Debt to Equity History and Analysis
Debt Level: XRAY's debt to equity ratio (28%) is considered satisfactory.
Reducing Debt: XRAY's debt to equity ratio has reduced from 54.7% to 28% over the past 5 years.
Balance Sheet
Inventory Level: XRAY has a low level of unsold assets or inventory.
Debt Coverage by Assets: XRAY's debt is covered by short term assets (assets are 1.3x debt).
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: XRAY is profitable, therefore cash runway is not a concern.
Forecast Cash Runway: XRAY is profitable, therefore cash runway is not a concern.
Next Steps
Dividend
What is DENTSPLY SIRONA's current dividend yield, its reliability and sustainability?
0.70%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: XRAY's dividend (0.7%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.45%).
High Dividend: XRAY's dividend (0.7%) is low compared to the top 25% of dividend payers in the US market (3.73%).
Stability and Growth of Payments
Stable Dividend: XRAY is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: XRAY is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: XRAY is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of XRAY's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.2yrs
Average management tenure
CEO
Don Casey (59yo)
2yrs
Tenure
US$11,338,542
Compensation
Mr. Donald M. Casey, Jr., also known as Don, serves as CEO and Director at DENTSPLY International Inc., since 2018. Mr. Casey has been Chief Executive Officer and a Director at Dentsply Sirona Inc. since ...
CEO Compensation Analysis
Compensation vs Market: Don's total compensation ($USD11.34M) is about average for companies of similar size in the US market ($USD10.79M).
Compensation vs Earnings: Insufficient data to compare Don's compensation with company performance.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2yrs | US$11.34m | 0.022% $2.8m | |
| EVP, General Counsel & Secretary | 2.3yrs | US$2.33m | 0.00078% $99.6k | |
| Senior Vice President of Chairside Consumables | 2.6yrs | US$1.48m | 0.0049% $631.1k | |
| Senior Vice President of EMEA RCO | 2.6yrs | US$1.52m | 0.011% $1.5m | |
| Executive VP & CFO | 0.5yrs | no data | no data | |
| Chief Technology Officer | 0.8yrs | no data | no data | |
| Vice President of Investor Relations | 0yrs | no data | no data | |
| Senior VP and Chief HR Officer & Communications | 0.3yrs | no data | no data | |
| Senior Vice President | 11.1yrs | US$1.35m | no data | |
| Chief Clinical Officer & VP | 0yrs | no data | no data |
2.2yrs
Average Tenure
55yo
Average Age
Experienced Management: XRAY's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 2yrs | US$11.34m | 0.022% $2.8m | |
| Independent Director | 14.8yrs | US$282.50k | 0.0092% $1.2m | |
| Non-Executive Chairman | 2.4yrs | US$398.88k | 0.010% $1.3m | |
| Independent Director | 4yrs | US$270.00k | 0.055% $7.0m | |
| Independent Director | 2.1yrs | US$261.75k | 0.0012% $155.9k | |
| Independent Director | 19yrs | US$270.00k | 0.0046% $581.3k | |
| Independent Director | 2.1yrs | US$264.16k | no data | |
| Independent Director | 0.8yrs | no data | 0.0045% $574.9k | |
| Independent Director | 4yrs | US$272.50k | 0.017% $2.2m | |
| Independent Director | 9yrs | US$272.50k | 0.0053% $683.5k |
3.2yrs
Average Tenure
63.5yo
Average Age
Experienced Board: XRAY's board of directors are considered experienced (3.2 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
DENTSPLY SIRONA Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: DENTSPLY SIRONA Inc.
- Ticker: XRAY
- Exchange: NasdaqGS
- Founded: 1899
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$12.775b
- Shares outstanding: 222.41m
- Website: https://www.dentsplysirona.com
Number of Employees
Location
- DENTSPLY SIRONA Inc.
- 13320 Ballantyne Corporate Place
- Charlotte
- North Carolina
- 28277
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| XRAY | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Aug 1987 |
| DY2 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Aug 1987 |
| 0I8F | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Aug 1987 |
| XRAY | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Aug 1987 |
| DY2 | ETLX (Eurotlx) | Yes | Common Stock | IT | EUR | Aug 1987 |
| XRAY34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH REP 1 COM USD0.01 | BR | BRL | May 2019 |
Biography
DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/02/22 00:33 |
| End of Day Share Price | 2020/02/21 00:00 |
| Earnings | 2019/09/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.